PARABON NANOLABS, INC.
Federal contract awards won by PARABON NANOLABS, INC. (UEI MXWGP7E3TFM8), 2017–2025 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
9
awards
3
expiring in 12 months
2
agencies
Category award history
11 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: HEBCO, INC. took Department of Defense 541511 work from PARABON NANOLABS, INC. (Sep 18, 2024).
Agencies buying from PARABON NANOLABS, INC.
What PARABON NANOLABS, INC. has provided
541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (5)541713 — RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY (2)541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) (1)541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) (1)
Awards
SBIR PHASE II T2S-0024 KIN- X PEDIGREE RECONSTRUCTION AND KINSHIP ANALYSIS
Department of Defense · $1,250,000 · Sep 24, 2025
SMALL BUSINESS INNOVATION RESEARCH PHASE II - A SYSTEM FOR ENGINEERING NANOCARRIERS ABLE TO TRANSPORT CARGO ACROSS THE BLOOD-BRAIN BARRIER.
Department of Defense · $1,099,912 · Feb 25, 2025
THIS PROJECT WILL CREATE A NOVEL SOFTWARE SYSTEM TO GENERATE BOTH RAPID AND DEEP INTELLIGENCE BY INFERRING DISTANT KINSHIP RELATIONSHIPS BETWEEN INDIVIDUALS AND RECONSTRUCTING FAMILIAL PEDIGREES.
Department of Defense · $1,099,957 · Sep 7, 2022
TO DEVELOP AND DEMONSTRATE A NOVEL, INNOVATIVE, NANOANTIBIOTICS PLATFORM FOR DESIGNING AND SYNTHESIZING NANOCARRIERS ABLE TO EFFECTIVELY DELIVER ANTIMICROBIAL PEPTIDES TO LUNG TISSUE TO TREAT PULMONARY INFECTIONS FROM AEROSOLIZED BIOTHREAT AGENTS.
Department of Defense · $1,099,989 · Jul 11, 2022
SUBSEQUENT PHASE II SBIR - YEAR 1
Department of Defense · $1,097,478 · Jan 20, 2022
SEQUENTIAL PHASE II SBIR - YEAR 1 - ORIGAMI ANTIBODIES FOR THREAT SENSING.
Department of Defense · $1,100,000 · Aug 28, 2020
SEQUENTIAL PHASE II SBIR - DESIGN SOFTWARE FOR DNA BASED SENSING NANO-ARCHITECTURES.
Department of Defense · $1,099,959 · Aug 28, 2020
THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A DNA-BASED HIV VACCINE THAT WILL STIMULATE PRODUCTION OF BROADLY NEUTRALIZING ANTIBODIES (BNABS) AGAINST HIV-1 ENVELOP PROTEIN (ENV) TRIMER ANTIGENS.
Department of Health and Human Services · $599,999 · Jun 17, 2019
IGF::OT::IGF PHASE II SBIR(SUBSEQUENT) THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP LOW COST, MOBILE, HAND HELD, SCANNER CAPABLE OF PERFORMING A HEAD SCAN OF A PERSON, THEN COLLECT GENETIC SAMPLES AND SCANNER IMAGES, AND ENHANCE THE EXISTING CAPABILITY USING THE EXPANDED DATA COLLECTION FOR BIOMETRIC PREDICTION.
Department of Defense · $2,596,940 · Aug 1, 2017